RAGUSA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.289
EU - Europa 1.145
AS - Asia 301
AF - Africa 80
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.824
Nazione #
US - Stati Uniti d'America 2.266
IT - Italia 542
SE - Svezia 341
BG - Bulgaria 110
CN - Cina 97
VN - Vietnam 79
SG - Singapore 61
DE - Germania 57
CI - Costa d'Avorio 39
GB - Regno Unito 27
CA - Canada 21
HK - Hong Kong 20
SN - Senegal 20
IQ - Iraq 19
NG - Nigeria 18
RU - Federazione Russa 16
PL - Polonia 11
IN - India 10
AT - Austria 8
FR - Francia 6
CZ - Repubblica Ceca 5
BE - Belgio 4
CH - Svizzera 4
TR - Turchia 4
UA - Ucraina 4
IR - Iran 3
JP - Giappone 3
NL - Olanda 3
AU - Australia 2
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
FI - Finlandia 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.824
Città #
Fairfield 400
Ashburn 215
Woodbridge 205
Chandler 179
Milan 174
Seattle 169
Cambridge 149
Houston 138
Wilmington 132
Serra 124
Sofia 110
New York 76
Princeton 72
Ann Arbor 58
Lawrence 46
Medford 42
Abidjan 39
Florence 38
Beijing 33
Dong Ket 27
Boulder 26
Redwood City 23
San Diego 23
Bremen 20
Dakar 20
Hong Kong 20
Pisa 20
Rome 20
Des Moines 19
Frankfurt am Main 18
Lagos 18
Sulaymaniyah 18
Ottawa 16
Nanjing 15
Carrara 13
Dearborn 12
Norwalk 11
Washington 11
London 9
Warsaw 9
Guangzhou 6
Chengdu 5
Livorno 5
Massa 5
Brussels 4
Changsha 4
Fremont 4
Kilburn 4
Ogden 4
San Francisco 4
Serpukhov 4
Shenyang 4
St Petersburg 4
Tianjin 4
Vienna 4
Agliana 3
Bern 3
Boardman 3
Dallas 3
Jiaxing 3
Lucca 3
Phoenix 3
Pomezia 3
Absecon 2
Alexandria 2
Bedford 2
Boston 2
Cascina 2
Castano Primo 2
Cavriglia 2
Gabbro 2
Gunzenhausen 2
Hanover 2
Hebei 2
Hefei 2
Islington 2
Kunming 2
Lancaster 2
Nanchang 2
Naples 2
Prague 2
Sant'Anastasia 2
Siena 2
Thornhill 2
Wuhan 2
Zhengzhou 2
Acton 1
Almaty 1
Altopascio 1
Amsterdam 1
Ardabil 1
Arezzo 1
Azogues 1
Bengaluru 1
Bhubaneswar 1
Bogotá 1
Boydton 1
Brdo 1
Capannori 1
Casalbordino 1
Totale 2.916
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 138
Sunitinib in the treatment of thyroid cancer 128
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 119
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 117
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 116
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 112
Novel treatment options for anaplastic thyroid cancer 100
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 99
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 99
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 99
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 99
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 92
Novel therapies for thyroid autoimmune diseases: An update 92
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 91
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 90
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis 89
Molecular testing in the diagnosis of differentiated thyroid carcinomas 88
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 88
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 87
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 82
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 82
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 82
New insight in endocrine-related adverse events associated to immune checkpoint blockade 82
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 81
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 81
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy 81
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 80
Chemokines in hyperthyroidism 78
Novel treatments for anaplastic thyroid carcinoma 78
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 78
The protective effect of myo-inositol on human thyrocytes 77
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 76
null 75
Immune and inflammatory cells in thyroid cancer microenvironment 75
Th1 chemokines in autoimmune endocrine disorders 72
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 69
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 67
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 61
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 58
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 57
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 56
Thyroid autoimmune disorders and cancer 53
Endocrine disruptors and thyroid autoimmunity 49
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 46
L-T4 Therapy in Enteric Malabsorptive Disorders 44
Precision Medicine in Graves’ Disease and Ophthalmopathy 43
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 39
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 35
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 30
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 30
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 24
Molecular features of aggressive thyroid cancer 22
Myoinositol in Autoimmune Thyroiditis 22
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 20
Teprotumumab for the treatment of thyroid eye disease 16
Chemokines in thyroid autoimmunity 14
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 13
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 12
Thyroid Metastasis from Primary Breast Cancer 9
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 4
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 3
Thyroid Autoimmunity and SARS-CoV-2 Infection 3
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 1
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity 1
Totale 4.104
Categoria #
all - tutte 11.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019220 0 0 0 0 0 0 0 0 27 40 83 70
2019/20201.011 101 42 83 50 65 90 104 112 195 73 59 37
2020/2021492 38 54 51 12 23 24 18 53 34 61 28 96
2021/2022715 13 14 28 47 109 92 32 33 67 59 56 165
2022/2023774 118 106 67 37 68 92 36 46 123 5 62 14
2023/2024729 76 79 123 101 125 135 55 24 11 0 0 0
Totale 4.104